These oncogenic signaling pathways rapidly increase Mcl-1 to promote cell survival, suggesting that Mcl-1 may be an important mediator of apoptotic escape and therapeutic resistance in many cancers, including breast cancers. This evidence concerns the gene MCL1 and breast cancer.